Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: Correlation with Ki-67 and p53 immunoreactivity

Gynecologic Oncology

Volumn 95, Issue 1, 2004, Pages 23-31

  Bar, Julia K ^a   Grelewski, Piotr ^a   Popiela, Andrzej ^a   Noga, Leszek ^a   Rabczyñski, Jerzy ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b 50 368 W ^*  (Poland)

Author keywords

CD44v6; Immunohistochemistry; Ki 67; Metastasis; Ovarian carcinomas; p53; Type IV collagen

Indexed keywords

CD44V6 ANTIGEN; COLLAGEN TYPE 4; KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; ASCITES FLUID; BENIGN TUMOR; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; OVARY CANCER; OVARY METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE SECTION; TUMOR CELL;

EID: 4644372401     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.06.046     Document Type: Article

References (32)

1. A.P. Makar, M. Baekelandt, C.G. Trope, and G.B. Kristensen The prognostic significance of residual disease, FIGO substage, tumor histology and grade in patients with FIGO stage III ovarian cancer Gynecol. Oncol. 56 1995 175 180
2. H.S. Berner, B. Davidson, A. Berner, B. Risberg, G.B. Kristensen, and C.G. Trope Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinomaâ€"diagnostic and prognostic implications Clin. Exp. Metastasis 18 2000 197 202
3. C.D. Capo-Chichi, E.R. Smith, D-H. Yang, I.H. Roland, L. Vanderveer, and C. Cohen Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis Cancer 95 8 2002 1802 1815
4. R. Engers, and H.E. Gabbert Mechanisms of tumor metastasis: cell biological aspects and clinical implications J. Cancer Res. Clin. Oncol. 126 2000 682 692
5. Y. Oka, I. Naito, K. Manabe, Y. Sado, H. Matsushima, and Y. Ninomiya Distribution of collagen type IV α1â€"6 chains in human normal colorectum and colorectal cancer demonstrated by immunofluorescence staining using chain-specific epitope-defined monoclonal antibodies J. Gastroenterol. Hepatol. 17 2002 980 986
6. A.R. Nelson, B. Fingleton, M.L. Rothenberg, and L.M. Matrisian Matrix metalloproteinases: biologic activity and clinical implications J. Clin. Oncol. 18 2000 1135 1149
7. M. Anttila, V.M. Kosma, H. Ji, X. Wei-Ling, J. Poulakka, and M. Juhola Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer J. Clin. Oncol. 16 8 1998 2591 2600
8. Y. Kiyozuka, H. Nakagawa, H. Senzaki, Y. Uemura, S. Adachi, and Y. Teramoto Bone morphogenetic protein-2 type IV collagen expression in psammoma body forming ovarian cancer Anticancer Res. 21 2001 1723 1730
9. Y. Kuwashima, T. Uehara, M. Kurosumi, K. Kishi, K. Shiromizu, and M. Matsuzawa Basement membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type IV collagen and laminin Eur. J. Gynaecol. Oncol. 16 1995 181 186
10. D-H. Yang, E.R. Smith, C. Cohen, H. Wu, C. Patriotis, and A.K. Godwin Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity Cancer 94 9 2002 2380 2392
11. G. Salles, M. Zain, W.M. Jiang, V.A. Boussiotis, and M.A. Shipp Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies Blood 82 1993 3539 3547
12. M. Kaufmann, K.H. Heider, H.P. Sinn, G. von Minckwitz, H. Ponta, and P. Herrlich CD44 variant exon epitopes in primary breast cancer and length of survival Lancet 345 1995 615 619
13. C. Kainz, P. Kohlberger, C. Tempfer, G. Sliutz, G. Gitsch, and A. Reinthaller Prognostic value of CD44 splice variants in human stage III cervical cancer Eur. J. Cancer 31A 10 1995 1706 1709
14. C. Kainz, and C. Tempfer CD44 as a differentiation marker and metastasis promoter in gynecological malignancies Cancer J. 10 6 1997 306 309
15. E. Darai, F. Walker Combrouze, A. Fouconnier, P. Madelenat, F. Potet, and J.Y. Scoazec Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomas Histopathology 32 2 1998 151 159
16. T. Yorishima, N. Nagai, and K. Ohama Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer Hiroshima J. Med. Sci. 46 1 1997 21 29
17. A.K. Sood, J.I. Sorosky, M. Dolan, B. Anderson, and R.E. Buller Distant metastases in ovarian cancer: association with p53 mutations Clin. Cancer Res. 5 1999 2485 2490
18. F. Buttitta, A. Marchetti, A. Gadducci, S. Pellegfini, M. Morganti, and V. Carnicelli p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study Br. J. Cancer 75 2 1997 230 235
19. S.C. Henzen-Longmans, E.J.H. Fieret, E.M.J.J. Berns, M.E.L. van der Burg, J.G.M. Klijn, and J.A. Foekens Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D Int. J. Cancer 57 1994 468 472
20. B.A. Goff, J.A. Ries, L.P. Els, M.D. Coltrera, and A.M. Gown Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure Gynecol. Oncol. 70 1998 378 385
21. W.J. Creasman Announcement, FIGO stages 1988. Revisions Gynecol. Oncol. 35 1989 125 127
22. R.H. Young, P.B. Clement, and R.E. Scully Surface epithelial†"stromal tumors S.S. Sternberg Diagnostic surgical pathology vol. 2 1999 Lippincott Williams & Wilkins Philadelphia 2319 2382
23. A. Harłozinska, J.K. Bar, M. Cisło, R. Richter, and J. Rabczyñski Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms Anal. Cell Pathol. 4 1 1992 1 12
24. B. Davidson, I. Goldberg, A. Berner, J.M. Nesland, V. Givant-Horwitz, and M. Bryne Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions Am. J. Clin. Pathol. 115 2001 517 524
25. H.S. Berner, B. Davidson, A. Berner, B. Risberg, and J.M. Nesland Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions Virchows Arch. 436 2000 330 335
26. B. Davidson, B. Risberg, A. Berner, J.M. Nesland, C.G. Trope, and G.B. Kristensen Expression of cell cycle proteins in ovarian carcinoma cells in serous effusionsâ€"Biological and prognostic implications Gynecol. Oncol. 83 2001 249 256
27. K.S. Tewari, A.S. Kyshtoobayeva, R.S. Mehta, I.-R. Yu, R.A. Burger, and P.J. Di Saia Biomarker conservation in primary and metastatic epithelial ovarian cancer Gynecol. Oncol. 78 2000 130 136
28. M.G. Daidone, E. Benini, B. Valentinis, G. Tomasic, G. Bolis, and A. Villa p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial†"stromal tumors Eur. J. Cancer 32A 1996 1388 1393
29. E. Ioachim, A. Charchanti, E. Briasoulis, V. Karavasilis, H. Tsanou, and D.L. Arvanitis Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin on breast cancer: their prognostic value and role in tumour invasion and progression Eur. J. Cancer 38 2002 2362 2370
30. E.E. Ioachim, S.E. Athanassiadou, S. Kamina, K. Carassavoglou, and N.J. Agnantis Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices Anticancer Res. 18 1998 1665 1670
31. G. Fassina, N. Ferrari, C. Brigati, R. Benelli, L. Santi, and D.M. Noonan Tissue inhibitors of metalloproteases: regulation and biological activities Clin. Exp. Metastasis 18 2000 111 120
32. T.A. Shahan, Z. Ziaie, S. Pasco, A. Fawzi, G. Bellon, and J.C. Monboisse Identification of CD47/integrin-associated protein and αγβ3 as two receptors for the α3(IV) chain of type IV collagen on tumor cells Cancer Res. 59 1999 4584 4590